<DOC>
<DOCNO>EP-0647641</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Substituted heterocyclylisoquinolinium salts and compositions and methods of usethereof.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31435	A61K31435	A61K31495	A61K31495	A61K3150	A61K3150	A61K31505	A61K31505	A61K3153	A61K3153	A61K31535	A61K31535	A61P2500	A61P2518	A61P2528	C07D47100	C07D47118	C07D49100	C07D49122	C07D49800	C07D49818	C07D49822	C07D51300	C07D51318	C07D51322	C07D51900	C07D51900	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P25	A61P25	A61P25	C07D471	C07D471	C07D491	C07D491	C07D498	C07D498	C07D498	C07D513	C07D513	C07D513	C07D519	C07D519	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Substitutued heterocyclylisoquinolinium salts of 
Formula 


pharmaceutical compositions containing them and methods for the 
treatment or prevention of neurodegenerative disorders or neurotoxic 

injuries utilizing them. 
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
STERLING WINTHROP INC
</APPLICANT-NAME>
<APPLICANT-NAME>
STERLING WINTHROP INC.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DORITY JOHN ALAN C O STERLING
</INVENTOR-NAME>
<INVENTOR-NAME>
EARLY WILLIAM GEORGE C O STERL
</INVENTOR-NAME>
<INVENTOR-NAME>
KUMAR VIRENDRA C O STERLING WI
</INVENTOR-NAME>
<INVENTOR-NAME>
MALLAMO JOHN PETER C O CEPHALO
</INVENTOR-NAME>
<INVENTOR-NAME>
MILLER MATHEW STEVEN C O STERL
</INVENTOR-NAME>
<INVENTOR-NAME>
SUBRAMANYAM CHAKRAPANI C O STE
</INVENTOR-NAME>
<INVENTOR-NAME>
DORITY, JOHN ALAN, C/O STERLING WINTHROP INC.
</INVENTOR-NAME>
<INVENTOR-NAME>
EARLY, WILLIAM GEORGE, C/O STERLING WINTHROP INC.
</INVENTOR-NAME>
<INVENTOR-NAME>
KUMAR, VIRENDRA, C/O STERLING WINTHROP INC.
</INVENTOR-NAME>
<INVENTOR-NAME>
MALLAMO, JOHN PETER, C/O CEPHALON INC.
</INVENTOR-NAME>
<INVENTOR-NAME>
MILLER, MATHEW STEVEN, C/O STERLING WINTHROP INC.
</INVENTOR-NAME>
<INVENTOR-NAME>
SUBRAMANYAM, CHAKRAPANI, C/O STERLING WINTHROP INC
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
The invention relates to substituted heterocyclylisoquinolinium 
salts, to compositions containing the same and to the 
method of use thereof in the treatment or prevention of neurodegenerative 
disorders or neurotoxic injuries. Bradsher et al., J Het. Chem. 1972, 9(2), 177-181, 
disclose 5,10,12,13-tetrahydro-1,2-diphenyl-11H-5,10-endocyclopent-1H-imidazo[1,2-b]isoquinolin-4-ium 
bromide, 
11-carbazol-9-yl-5,10-dihydro-1-(3-trifluoromethylphenyl)-2-phenyl-5,10-ethano-1H-imidazo[1,2-b]isoquinolin-4-ium 
bromide, and 
12-(2-pyrrolidinone-1-yl)-6,11-ethano-6,11-dihydro-3-phenyl-pyrazino[1,2-b]isoquinolin-5-ium 
bromide; as well as a series of 
Diels-Alder adducts prepared from 3-R-pyrazino[1,2-b]isoquinolin-5-ium 
2-oxide perchlorates (R=H,CH₃,Ph) and cyclopentadiene, 
N-vinyl-2-pyrrolidinone, 9-vinylcarbazole and ethylvinyl ether. No 
utility is disclosed for these compounds. The present invention relates to compounds of Formula I; 
wherein:
 
   R¹ is hydrogen, or lower-alkyl;
 
   R² and R³ are independently hydrogen, or lower-alkyl; 
or R² and R³ together form a cycloalkyl ring, or a lower-alkylidene 
group;
 
   R⁴ and R⁵ are independently lower-alkynyl, lower-alkoxy, 
phenyl (or phenyl substituted by lower-alkoxy, halogen, 
lower-alkyl, polyfluorolower-alkyl, polychlorolower-alkyl or 
hydroxy), a 5- or 6-membered monocyclic aromatic heterocyclic ring  
 
system containing from one to three, the same or different, heteroatoms 
selected from the group consisting of nitrogen, oxygen and 
sulfur; a 9- or 10-membered bicyclic aromatic heterocyclic ring 
system containing from one to two, the same or different, heteroatoms 
selected from the group consisting of oxygen, nitrogen and 
sulfur; or a 5- or 6-membered monocyclic nonaromatic heterocyclic 
ring system containing from one to two, the same or different, heteroatoms 
selected from the group consisting of nitrogen, oxygen and 
sulfur; or said 5- or 6-membered monocyclic aromatic or said non-aromatic 
heterocyclic ring system or said 9- or 10-membered bicyclic 
aromatic heterocyclic ring system substituted on any available carbon 
atom thereof by hydroxy, lower-alkyl, oxo, nitro, halogen, or lower-alkoxy; 
or on any available nitrogen atom thereof by lower-alkyl, 
trilower-alkylsilyl, trilower-alkylsilyl-lower-alkoxy-lower-alkyl, or 
phenyl-lower-alkyl (or said phenyl-lower-alkyl group substituted on 
the phenyl group by lower-alkoxy, lower-alkyl, or halogen);
 
   or R² and R⁴ and/or R³ and R⁵ taken together with the 
carbon atoms to which they are
</DESCRIPTION>
<CLAIMS>
A compound of Formula: 
 

wherein: 
   R¹ is hydrogen, or lower-alkyl; 

   R² and R³ are independently hydrogen, or lower-alkyl; 
or R² and R³ together form a cycloalkyl ring, or a lower-alkylidene 

group; 
   R⁴ and R⁵ are independently lower-alkynyl, lower-alkoxy, 

phenyl (or phenyl substituted by lower-alkoxy, halogen, 
lower-alkyl, polyfluorolower-alkyl, polychlorolower-alkyl or 

hydroxy), a 5- or 6-membered monocyclic aromatic heterocyclic ring 
system containing from one to three, the same or different, heteroatoms 

selected from the group consisting of nitrogen, oxygen and 
sulfur; a 9- or 10-membered bicyclic aromatic heterocyclic ring 

system containing from one to two, the same or different, heteroatoms 
selected from the group consisting of oxygen, nitrogen and 

sulfur; or a 5- or 6-membered monocyclic nonaromatic heterocyclic 
ring system containing from one to two, the same or different, heteroatoms 

selected from the group consisting of nitrogen, oxygen and 
sulfur; or said 5- or 6-membered monocyclic aromatic or said non-aromatic 

heterocyclic ring system or said 9- or 10-membered bicyclic 
aromatic heterocyclic ring system substituted on any available carbon 

atom thereof by hydroxy, lower-alkyl, oxo, nitro, halogen, or lower-alkoxy; 
or on any available nitrogen atom thereof by lower-alkyl, 

trilower-alkylsilyl, trilower-alkylsilyl-lower-alkoxy-lower-alkyl, or 
phenyl-lower-alkyl (or said phenyl-lower-alkyl group substituted on 

the phenyl group by lower-alkoxy, lower-alkyl, or halogen);
 

   or R² and R⁴ and/or R³ and R⁵ taken together with the 
carbon atoms to which they are attached form a bicyclic ring system 

of Formula 
 

wherein 
   B is: phenyl, or a 5- or 6-membered monocyclic 

aromatic heterocyclic ring system containing from one to three, the 
same or different, heteroatoms selected from the group consisting of 

nitrogen, oxygen and sulfur, (or said B ring substituted on any 
available carbon atom thereof by lower-alkoxy, or lower-alkyl), and 

n is an integer from one to three; 
   R⁶ is hydrogen, or from one to four, the same or 

different, substituents in any of the 7-, 8-, 9-, or 10-positions (if A is a 
six-membered ring), or in any of the 6-, 7-, 8-, or 9- position (if A is a 

five-membered ring) selected from the group consisting of lower-alkyl, 
lower-alkanoyloxy, halogen, nitro, hydroxy, lower-alkoxy, 

methylenedioxy, polychlorolower-alkyl, OCO(CH₂)mC(O)O alkyl, 
OC(O)alkyl, C(O)Oalkyl, CO₂⁻, carboxy, sulfo, SO₃⁻, PO₃H, PO₃⁻, 

cyano, polyfluorolower-alkyl, OC(O) alkyl-CH=CH-alkyl, 
OC(O)-lower-alkenyl-C(O)alkyl, alkoxy, OC(O)alkylC(O)Oalkyl, 

amino, and lower-alkylsulfonylamino, wherein m is an integer from 
one to four; 

   A together with the carbon and nitrogen atoms to which 
it is attached forms a 5- or 6-membered monocyclic aromatic heterocycle 

containing from two to three, the same or different, heteroatoms 
selected from the group consisting of nitrogen, oxygen and sulfur (or 

said 5- or 6-membered monocyclic aromatic heterocycle substituted 
on any available carbon atom thereof by hydroxy, 

OC(O)alkyl-CH=CH-alkyl, OC(O)alkyl, 
OC(O)lower-alkenyl-C(O)Oalkyl, alkoxy, OC(O)alkylC(O)Oalkyl, 

nitro, amino, lower-alkylsulfonylamino, lower-alkyl, lower-alkoxy, 
or halogen; or on any available nitrogen atom thereof by phenyl (or 

 
said phenyl group substituted by lower-alkoxy, lower-alkyl or 

halogen), diphenylmethyl, naphthyl-lower-alkyl (or said naphthyl-lower-alkyl 
group substituted on the naphthyl group by lower-alkoxy, 

lower-alkyl or halogen), lower-alkyl, or phenyl-lower-alkyl (or said 
phenyl-lower-alkyl group substituted on the phenyl group by lower-alkoxy, 

lower-alkyl or halogen)); 
   X⁻ is an anion; and p is zero when R⁶ is a negatively 

charged radical, and p is one when R⁶ is other than a negatively 
charged radical; 

or a pharmaceutically acceptable acid-addition salt of basic members 
thereof; or a hydrate thereof; or a stereoisomer thereof. 
A compound according to claim 1 wherein: 
   R¹ is hydrogen, or lower-alkyl; 

   R² and R³ are independently hydrogen, or lower-alkyl; 
or R² and R³ together form a cycloalkyl ring, or a lower-alkylidene 

group; 
   R⁴ and R⁵ are independently lower-alkynyl, lower-alkoxy, 

phenyl (or phenyl substituted by lower-alkoxy, halogen, 
lower-alkyl, polyfluorolower-alkyl, polychlorolower-alkyl, or 

hydroxy), a 5- or 6-membered monocyclic aromatic heterocyclic ring 
system containing from one to three, the same or different, heteroatoms 

selected from the group consisting of nitrogen, oxygen and 
sulfur; a 9- or 10-membered bicyclic aromatic heterocyclic ring 

system containing from one to two, the same or different, heteroatoms 
selected from the group consisting of oxygen, nitrogen and 

sulfur, or a 5- or 6-membered monocyclic nonaromatic heterocyclic 
ring system containing from one to two, the same or different, heteroatoms 

selected from the group consisting of nitrogen, oxygen and 
sulfur ; 
or said 5- or 6-membered monocyclic aromatic or said non-aromatic 
heterocyclic ring system or said 9- or 10-membered bicyclic 

aromatic heterocyclic ring system substituted on any available carbon 
atom thereof by lower-alkyl, oxo, nitro, halogen, or lower-alkoxy; or 

on any available nitrogen atom thereof by lower-alkyl, trilower-alkylsilyl, 
trilower-alkylsilyl-lower-alkoxy-lower-alkyl, or phenyl-lower-alkyl 

(or said phenyl-lower-alkyl group substituted on the phenyl 
group by lower-alkoxy, lower-alkyl, or halogen);

 
   or R² and R⁴ and/or R³ and R⁵ taken together with the 

carbon atoms to which they are attached form a bicyclic ring system 
of Formula 

 
wherein 

   B is: phenyl, or a 5- or 6-membered monocyclic 
aromatic heterocyclic ring system containing from one to three, the 

same or different, heteroatoms selected from the group consisting of 
nitrogen, oxygen and sulfur, (or said B ring substituted on any 

available carbon atom thereof by lower-alkoxy, or lower-alkyl), and 
n is an integer from one to three; 

   R⁶ is hydrogen, or from one to four, the same or 
different, substituents in any of the 7-, 8-, 9-, or 10-positions (if A is a 

six-membered ring), or in any of the 6-, 7-, 8-, or 9- position (if A is a 
five-membered ring) selected from the group consisting of lower-alkyl, 

lower-alkanoyloxy, halogen, nitro, hydroxy, lower-alkoxy, 
methylenedioxy, polychlorolower-alkyl, OCO(CH₂)mC(O)O alkyl, 

OC(O)alkyl, C(O)Oalkyl, CO₂⁻, carboxy, sulfo, SO₃⁻, PO₃H, PO₃⁻, 
cyano and polyfluorolower-alkyl, wherein m is an integer from 

one to four; 
   A together with the carbon and nitrogen atoms to which 

it is attached forms a 5- or 6-membered monocyclic aromatic heterocycle 
containing from two to three, the same or different, heteroatoms 

selected from the group consisting of nitrogen, oxygen and sulfur (or 
said 5- or 6-membered monocyclic aromatic heterocycle substituted 

on any available carbon atom thereof by lower-alkyl, lower-alkoxy, 
or halogen; or on any available nitrogen atom thereof by lower-alkyl, 

or phenyl-lower-alkyl (or said phenyl-lower-alkyl group substituted 
on the phenyl group by lower-alkoxy, lower-alkyl or halogen)); 

   X⁻ is an anion; and p is zero when R⁶ is a negatively 
charged radical, and p is one when R⁶ is other than a negatively 

charged radical;
 

or a pharmaceutically acceptable acid-addition salt of basic members 
thereof; or a hydrate thereof; or a stereoisomer thereof. 
A compound according to claim 2 wherein R² and R³ are 
independently hydrogen, or lower-alkyl; and R⁶ is hydrogen, or from 

one to two, the same or different, substitutents in any of the 
7-,8-,9-, or 10-positions (if A is a six-membered ring), or in any of 

the 6-,7-,8 or 9-positions (if A is a five-membered ring) selected from 
the group consisting of lower-alkyl, halogen, hydroxy, lower-alkoxy 

and polyfluorolower-alkyl. 
A compound according to claim 3 wherein R⁶ is hydrogen, 
or one substituent in any of the 7-,8-,9- or 10-positions (if A is a six-membered 

ring), or in any of the 6-,7-,8 or 9-positions (if A is a five-membered 
ring) selected from the group consisting of lower-alkyl, 

halogen, hydroxy, and lower-alkoxy. 
A compound according to claim 4 wherein R⁶ is hydrogen, 
or one lower-alkoxy substituent in any of the 7-,8-,9- or 10-positions 

(if A is a six-membered ring), or in any of the 6-,7-,8 or 9-positions 
(if A is a five-membered ring); and R¹ is hydrogen. 
A compound according to claim 2 wherein: 
   R⁴ and R⁵ are independently lower-alkynyl, lower-alkoxy, 

phenyl (or phenyl substituted by lower-alkoxy, halogen, 
lower-alkyl, polyfluorolower-alkyl, polychlorolower-alkyl, or 

hydroxy), a 5- or 6-membered monocyclic aromatic heterocyclic ring 
system containing from one to three, the same or different, heteroatoms 

selected from the group consisting of nitrogen, oxygen and 
sulfur; a 9- or 10-membered bicyclic aromatic heterocyclic ring 

system containing from one to two, the same or different, heteroatoms 
selected from the group consisting of oxygen, nitrogen and 

sulfur, or said 5- or 6-membered monocyclic or said 
9- or 10-membered bicyclic aromatic heterocyclic ring system 

substituted on any available carbon atom thereof by lower-alkyl, oxo, 
or lower-alkoxy; or on any available nitrogen atom thereof by lower-alkyl, 

or phenyl-lower-alkyl (or said phenyl-lower-alkyl group 
substituted on the phenyl group by lower-alkoxy, lower-alkyl or 

halogen). 
A compound according to claim 6 wherein 
   R⁴ and R⁵ are independently lower-alkoxy, phenyl (or 

phenyl substituted by lower-alkoxy, halogen, lower-alkyl, polyfluorolower-alkyl, 
polychloro-lower-alkyl, or hydroxy), or a 

5- or 6-membered monocyclic aromatic heterocyclic ring system 
containing from one to three, the same or different, heteroatoms 

selected from the group consisting of nitrogen, oxygen and sulfur (or 
said 5- or 6-membered monocyclic aromatic heterocyclic ring system 

substituted on any available carbon atom thereof by lower-alkyl, oxo, 
or lower-alkoxy; or on any available nitrogen atom thererof by lower-alkyl, 

or phenyl-lower-alkyl (or said phenyl-lower-alkyl group 
substituted on the phenyl group by lower-alkoxy, lower-alkyl or 

halogen). 
A compound according to claim 7 wherein: 
   R4 and R5 are independently lower-alkoxy, phenyl (or 

phenyl substituted by lower-alkoxy, halogen, lower-alkyl, polyfluorolower-alkyl, 
polychloro-lower-alkyl, or hydroxy), or a 5-membered 

monocyclic aromatic heterocyclic ring system containing from one to 
three, the same or different, heteroatoms selected from the group 

consisting of nitrogen, oxygen, and sulfur (or said 5-membered 
monocyclic aromatic heterocyclic ring system substituted on any 

available carbon atom thereof by lower-alkyl, oxo, or lower-alkoxy; 
or on any available nitrogen atom thereof by lower-alkyl, or phenyl-lower-alkyl 

(or said phenyl-lower-alkyl group substituted on the 
phenyl group by lower-alkoxy, lower-alkyl or halogen); and 

   A together with the carbon and nitrogen atoms to which 
it is attached forms a 5-membered monocyclic aromatic heterocycle 

containing from two-to three, the same or different, heteroatoms 
selected from the group consisting of nitrogen, oxygen and sulfur (or 

said 5-membered monocyclic aromatic heterocycle substituted on any 
available carbon atom thereof by lower-alkyl, lower-alkoxy, or 

halogen; or on any available nitrogen atom thereof by lower-alkyl, or 
phenyl-lower-alkyl (or said phenyl-lower-alkyl group substituted on 

the phenyl group by lower-alkoxy, lower alkyl or halogen). 
A compound according to claim 8 wherein R² and R³ are 
independently hydrogen, or lower-alkyl; and R⁶ is hydrogen, or from 

one to two, the same or different, substituents in any of the 
6-,7-,8 or 9-positions selected from the group consisting of lower-alkyl, 

halogen, hydroxy, lower-alkoxy and polyfluoro-lower-alkyl. 
A compound according to claim 9 wherein R⁶ is hydrogen, 
or one substituent in any of the 6-,7-,8 or 9-positions selected from 

the group consisting of lower-alkyl, halogen, hydroxy, and lower-alkoxy. 
A compound according to claim 10 wherein: 
   R⁴ and R⁵ are independently lower-alkoxy, phenyl, or a 

5-membered monocyclic aromatic heterocyclic ring system 
containing from one to two, the same or different, heteroatoms 

selected from the group consisting of nitrogen and oxygen (or said 
5-membered monocyclic aromatic heterocyclic ring system 

substituted on any available carbon atom thereof by oxo, or on any 
available nitrogen atom thereof by phenyl-lower-alkyl (or said 

phenyl-lower-alkyl group substituted on the phenyl group by lower-alkoxy); 

and 
   A together with the carbon and nitrogen atoms to which 

it is attached forms a 5-membered monocyclic aromatic heterocycle 
containing from two to three, the same or different, heteroatoms 

selected from the group consisting of nitrogen and sulfur (or said 
5-membered monocyclic aromatic heterocycle substituted on any 

available carbon atom thereof by lower-alkyl; or on any available 
nitrogen atom thereof by lower-alkyl, or phenyl-lower-alkyl (or said 

phenyl-lower-alkyl group substituted on the phenyl group by lower 
alkoxy). 
A compound according to claim 11 wherein R⁶ is 
hydrogen, or one lower-alkoxy substituent in any of the 

6-,7-,8- or 9-positions; and R¹ is hydrogen. 
A compound according to claim 12 wherein: 
   R⁴ and R⁵ are independently ethoxy, phenyl, or a 

5-membered monocyclic aromatic heterocyclic ring system selected 
from furanyl or pyrazolyl (or said 5-membered aromatic heterocyclic 

ring system substituted on any available carbon atom thereof by oxo, 
or on any available nitrogen atom thereof by methoxyphenylmethyl); 

and A together with the carbon and nitrogen atoms to which it is 
attached forms a 5-membered monocyclic aromatic heterocycle 

selected from thiazolyl, imidazolyl, or triazolyl (or said 5-membered 
monocyclic aromatic heterocycle substituted on any available carbon 

atom thereof by methyl; or on any available nitrogen atom thereof by 
methyl, phenylmethyl, or methoxyphenylmethyl. 
A compound according to claim 13 wherein R² and R³ 
are independently hydrogen or methyl, and R⁶ is hydrogen or 

9-methoxy. 
11,11-Di(3-Furanyl)-5,10-ethano-5,10-dihydrothiazolo[3,2-b]-isoquinolinium 

X⁻. 
(+)- 11,11-Di(3-furanyl)-5,10-ethano-5,10-dihydrothiazolo[3,2-b]-isoquinolinium 

X⁻. 
(+)-11,11-Di(3-furanyl)-5,10-ethano-5,10-dihydrothiazolo[3,2-b]-isoquinolinium 

chloride. 
A compound according to claim 1 wherein R⁶ is from one 
to four, the same or different, substituents in any of the 

7-, 8-, 9-, or 10- positions (if A is a six-membered ring), or in any of 
the 6-, 7-, 8-, 9- positions (if A is a five-membered ring) selected 

from the group consisting of OC(O)alkyl-CH=CH-alkyl, 
OC(O)-lower-alkenyl-C(O)Oalkyl, alkoxy, OC(O)alkylC(O)Oalkyl, 

amino and lower-alkylsulfonylamino. 
A compound according to claim 1 wherein A together with 
the carbon and nitrogen atoms to which it is attacked forms a 

5- or 6-membered monocyclic aromatic heterocycle containing from 
two to three, the same or different, heteroatoms selected from the 

group consisting of nitrogen, oxygen, sulfur with said 
5- or 6-membered monocyclic aromatic heterocycle being substituted 

on any available carbon atom thereof by hydroxy, 
 

OC(O)alkyl-CH=CH-alkyl, OC(O)alkyl, 
OC(O)-lower-alkenyl-C(O)Oalkyl, alkoxy, OC(O)alkylC(O)Oalkyl, 

nitro, amino or lower-alkylsulfonylamino; or on any available 
nitrogen atom thereof by phenyl (or said phenyl group substituted by 

lower-alkoxy, lower-alkyl or halogen), diphenylmethyl, naphthyl-lower-alkyl 
(or said naphthyl-lower-alkyl group substituted on the 

naphthyl group by lower-alkoxy, lower-alkyl or halogen). 
A compound according to claim 19 wherein: 
   R⁴ and R⁵ are independently a 5-membered monocyclic 

aromatic heterocyclic ring system selected from the group consisting 
of furanyl, thienyl, oxazolyl, thiazolyl, pyrazolyl, triazolyl, pyrrolyl, 

imidazolyl, isoxazolyl, oxadiazolyl, and thiadiazolyl; 
   R⁶ is hydrogen, or one substituent in any of the 

6-, 7-, 8-, 9-positions selected from the group consisting of lower-alkoxy 
and hydroxy; 

   A together with the carbon and nitrogen atoms to which 
it is attached forms a 5-membered monocyclic aromatic heterocycle 

selected from the group consisting of imidazolyl and triazolyl, with 
said 5-membered monocyclic aromatic heterocycle being substituted 

on any available nitrogen atom thereof by phenyl, diphenylmethyl, or 
naphthyl-lower-alkyl; and 

   X⁻ is an anion. 
A compound according to claim 20 wherein: 
   R¹, R², R³ and R⁶ are hydrogen; 

   R⁴ and R⁵ are furanyl; 
   A together with the carbon and nitrogen atoms to which 

it is attached forms an imidazole ring which is substituted on the 
available nitrogen atom thereof by phenyl, diphenylmethyl, or 

naphthylmethyl; and 
   X⁻ is an anion. 
A pharmaceutical composition which comprises a 
compound according to claim 1 together with a pharmaceutically 

acceptable carrier, adjuvant diluent or vehicle. 
A pharmaceutical composition which comprises a 
compound according to any one of claims 2 to 21 together with a 

pharmaceutically acceptable carrier, adjuvant, diluent or vehicle. 
The use of a compound according to claim 1 for the 
preparation of a medicament for the treatment or prevention of 

neurodegenerative disorders or neurotoxic injuries in a patient in need 
of such treatment. 
The use of a compound according to any one of claims 
claim 2 to 21 for the preparation of a medicament for the treatment 

or prevention of neurodegenerative disorders or neurotoxic injuries in 
a patient in need of such treatment. 
A use according to either of claims 24 and 25 wherein said 
neurotoxic injuries are associated with ischemic, hypoxic, or 

hypoglycemic conditions. 
A use according to claim 26 wherein said ischemic, 
hypoxic, or hypoglycemic conditions are associated with stroke. 
</CLAIMS>
</TEXT>
</DOC>
